To date, much attention has focused on changes in circulating Lp-PLA2 and disease (arising from epidemiological studies), and has highlighted that Lp-PLA2 is upregulated in conditions of obesity, inflammation and cardiovascular disease (CVD) [4–7]. The gene discussed is PLA2G7; the disease is obesity due to melanocortin 4 receptor deficiency.